known
subject
rhinovirus
commonli
detect
acut
ill
asymptomat
infant
children
find
may
repres
new
infect
prolong
presenc
rhinoviru
rna
respiratori
tract
studi
add
young
otherwis
healthi
infant
shed
rna
rhinoviru
strain
rare
persist
longer
day
abstract
background
current
molecular
diagnost
method
detect
rhinoviru
rna
high
proport
asymptomat
infant
children
rais
question
clinic
signific
find
studi
investig
preval
prolong
rhinoviru
rna
presenc
upper
respiratori
tract
infant
first
year
life
longitudin
studi
infant
follow
birth
month
nasopharyng
specimen
collect
monthli
month
month
upper
respiratori
infect
rhinovirus
detect
quantit
reversetranscript
polymeras
chain
reaction
presenc
repeat
rhinoviru
rna
evalu
nucleotid
sequenc
analysi
total
specimen
infant
studi
distinct
rhinoviru
infect
infant
identifi
followup
specimen
avail
within
day
infect
creat
sampl
set
assess
prolong
rhinoviru
presenc
infect
involv
detect
rhinoviru
strain
repeat
specimen
includ
event
prolong
presenc
strain
detect
specimen
collect
day
apart
repres
evalu
rhinoviru
infect
event
rhinoviru
strain
replac
differ
strain
within
interv
repres
infect
conclus
although
rhinoviru
infect
common
healthi
infant
prolong
presenc
rhinoviru
rna
respiratori
tract
upper
respiratori
infect
uncommon
detect
rhinoviru
rna
infant
like
repres
infect
within
period
key
word
rhinoviru
rna
pcr
upper
respiratori
tract
infect
persist
abbrevi
aomacut
otiti
media
cdnacomplementari
dna
pcrpolymeras
chain
reaction
qpcrquantit
polymeras
chain
reaction
qrtpcrquantit
realtim
reversetranscript
polymeras
chain
reaction
uriupp
respiratori
infect
utmbunivers
texa
medic
branch
dr
loeffelholz
coconceptu
codesign
studi
wrote
initi
manuscript
dr
trujillo
coordin
data
collect
dr
pyle
conceptu
supervis
molecular
virolog
studi
review
revis
manuscript
mr
miller
perform
molecular
virolog
studi
provid
interpret
data
inclus
manuscript
dr
alvarezfernandez
supervis
data
collect
dr
pong
perform
molecular
virolog
studi
perform
data
collect
analysi
dr
chonmaitre
conceptu
design
studi
provid
overal
studi
supervis
revis
manuscript
author
approv
final
manuscript
submit
agre
account
aspect
work
doi
rhinovirus
common
caus
upper
respiratori
tract
infect
uri
recent
studi
shown
increas
preval
asymptomat
rhinoviru
infect
picornaviru
nucleic
acid
typic
shed
upper
respiratori
tract
week
infect
studi
adult
volunt
show
cultivat
rhinovirus
routin
recov
week
infect
recurr
rhinoviru
infect
describ
patient
asthma
risk
develop
asthma
recurr
infect
like
due
differ
rhinoviru
strain
persist
strain
prolong
durat
rhinoviru
infect
describ
immunocompromis
patient
month
pediatr
stem
cell
transplant
patient
month
adult
recipi
lung
transplant
month
adult
patient
primari
hypogammaglobulinemia
date
studi
persist
novel
repeat
rhinoviru
infect
infant
first
year
life
human
first
expos
virus
report
molecular
diagnost
method
polymeras
chain
reaction
pcr
use
frequent
place
viral
cultur
detect
respiratori
virus
includ
rhinovirus
pcr
sensit
viral
cultur
characterist
togeth
abil
respiratori
virus
adenoviru
picornavirus
persist
infect
caus
asymptomat
infect
confound
interpret
posit
pcr
result
applic
cutoff
valu
quantit
pcr
may
identifi
clinic
relev
rhinoviru
infect
largescal
longitudin
studi
involv
rhinoviru
strain
character
lack
particularli
infant
children
without
underli
condit
studi
involv
children
underli
ill
strain
character
absent
limit
previous
show
sequenti
specimen
children
uri
frequent
posit
rhinoviru
aim
studi
character
rhinovirus
detect
repeatedli
sequenti
sampl
differenti
new
infect
prolong
presenc
viral
nucleic
acid
herein
describ
result
sequenc
analysi
rhinoviru
rna
detect
nasopharyng
specimen
infant
uri
episod
monthli
asymptomat
visit
analysi
perform
use
specimen
collect
part
prospect
studi
determin
preval
risk
uri
acut
otiti
media
aom
develop
first
year
life
subject
enrol
octob
april
univers
texa
medic
branch
utmb
galveston
studi
subject
recruit
utmb
newborn
nurseri
primari
care
pediatr
clinic
healthi
resid
galveston
preterm
infant
major
medic
problem
anatom
physiolog
defect
ear
nasopharynx
exclud
subject
enrol
near
birth
month
age
follow
first
aom
episod
month
age
subject
complet
studi
age
month
aom
develop
month
follow
month
aom
occurr
nasopharyng
swab
collect
month
month
subject
still
remain
studi
followup
period
parent
instruct
report
studi
team
soon
subject
began
develop
cold
symptom
nasal
stuffi
runni
nose
cough
sore
throat
without
constitut
symptom
fever
decreas
appetit
restless
sleep
institut
review
board
utmb
approv
studi
protocol
written
inform
consent
obtain
parent
behalf
infant
train
personnel
collect
nasopharyng
swab
specimen
monthli
visit
introduc
flock
swab
floqswab
copan
diagnost
murrieta
ca
nose
resist
met
swab
rotat
gentli
swab
place
tube
eswab
transport
medium
copan
diagnost
transport
laboratori
ice
aliquot
kept
frozen
test
uri
episod
addit
nasopharyng
secret
collect
use
vacuum
suction
mucu
trap
describ
previous
highthroughput
quantit
realtim
reversetranscript
pcr
qrtpcr
assay
use
detect
rhinoviru
respiratori
specimen
describ
previous
briefli
nucleic
acid
extract
specimen
use
magmax
total
nucleic
acid
isol
kit
ambionappli
biosystem
austin
tx
biosprint
extract
platform
qiagen
valencia
ca
complementari
dna
cdna
synthes
extract
rna
use
iscript
synthesi
kit
biorad
hercul
ca
revers
transcript
complet
biorad
thermocycl
gener
cdna
analyz
immedi
store
cdna
templat
evalu
use
quantit
pcr
qpcr
assay
primer
amplifi
untransl
region
rhinoviru
separ
qpcr
human
dehydrogenas
gapdh
use
evalu
rna
qualiti
taqman
probe
sigmaaldrich
st
loui
mo
integr
dna
technolog
coralvil
ia
articl
use
quantifi
specif
amplif
reaction
sequenc
analysi
nontransl
region
rhinoviru
perform
pyrosequenc
use
seminest
assay
use
previous
report
rhinoviru
realtim
qrtpcr
amplim
sequenc
rhinoviru
nontransl
region
suitabl
approach
evalu
shortterm
transmiss
briefli
ml
iq
supermix
biorad
mix
within
pcr
reaction
contain
nm
biotinyl
forward
primer
biotintggacaaggtgcgaagagc
revers
primer
ggttagccgcattcaggg
ml
rhinoviru
qpcr
amplim
nucleasefre
water
volum
thermocycl
complet
use
biorad
thermocycl
follow
protocol
minut
second
minut
repeat
time
minut
indefinit
hold
gener
biotinyl
pcr
product
pyrosequenc
use
pyromark
gold
reagent
pyromark
id
platform
accord
manufactur
instruct
qiagen
amplim
specif
sequenc
primer
tagccgcattcaggg
use
final
concentr
mm
combin
cyclic
dispens
gcat
verifi
prolong
presenc
rhinoviru
rna
sampl
case
persist
strain
identifi
pyrosequenc
subject
sangerbas
sequenc
region
within
nontransl
region
pcr
perform
use
ml
redtaqreadymix
sigmaaldrich
nm
forward
revers
primer
ml
cdna
templat
nucleasefre
water
pcr
product
clone
use
topo
ta
clone
kit
invitrogen
carlsbad
ca
repres
plasmid
purifi
isol
bacteri
coloni
sangersequenc
seqwright
houston
tx
result
analyz
use
genbankblast
clustal
omega
align
function
phylogenet
analysi
perform
use
inform
genomiqu
et
structual
web
portal
http
cgisimplephylogenycgi
report
includ
infant
studi
consecut
period
winter
season
infant
male
white
black
asian
one
hundr
eighti
infant
hispan
nonhispan
fortyon
infant
follow
month
month
month
total
specimen
collect
novemb
octob
infant
test
rhinoviru
qrtpcr
mean
specimen
per
infant
total
infant
test
posit
rhinoviru
least
figur
show
flow
diagram
number
subject
specimen
includ
studi
rhinoviru
rna
detect
specimen
averag
rhinoviru
isol
per
infant
total
specimen
evalu
valid
rhinoviru
nucleotid
sequenc
result
rhinovirusposit
specimen
consid
rhinoviru
rna
isol
sequenc
result
compar
sampl
patient
time
repeat
posit
rhinoviru
strain
identifi
repres
prolong
persist
distinct
rhinoviru
infect
figur
show
hypothet
subject
terminolog
use
studi
overal
distinct
rhinoviru
infect
infant
identifi
number
rhinoviru
infect
studi
period
shown
fig
occurr
rhinoviru
strain
replac
differ
strain
within
interv
repres
rhinoviru
infect
prolong
presenc
rhinoviru
rna
defin
presenc
rhinoviru
strain
longer
day
without
interven
neg
specimen
identifi
case
prolong
rhinoviru
presenc
followup
specimen
neg
particular
rhinoviru
strain
must
collect
within
day
followup
specimen
posit
rhinoviru
strain
could
collect
interv
restrict
day
uniqu
rhinoviru
infect
avail
followup
specimen
within
day
show
prolong
presenc
rhinoviru
strain
therefor
uniqu
evalu
rhinoviru
infect
infant
serv
sampl
set
assess
prolong
presenc
rhinoviru
addit
infect
followup
specimen
collect
day
followup
specimen
collect
day
either
followup
specimen
specimen
collect
day
howev
infect
includ
final
analysi
distinct
rhinoviru
infect
analyz
followup
specimen
neg
specif
rhinoviru
strain
infant
rhinoviru
infect
identifi
singl
rhinovirusposit
sampl
infant
rhinoviru
isol
distinct
rhinoviru
infect
repres
rhinoviru
isol
followup
specimen
neg
rhinoviru
strain
anoth
infect
consist
rhinoviru
strain
detect
repeatedli
also
evalu
symptom
pattern
associ
case
prolong
rhinoviru
presenc
result
reveal
differ
symptom
pattern
initi
symptomat
rhinoviru
rna
detect
resolut
symptom
case
case
symptomat
throughout
case
case
asymptomat
throughout
case
asymptomat
first
detect
later
develop
symptom
case
case
period
prolong
rhinoviru
rna
presenc
either
symptom
throughout
initi
asymptomat
symptomat
later
case
viral
load
increas
log
copiesml
day
respect
contrast
period
prolong
rhinoviru
rna
presenc
asymptomat
throughout
initi
symptomat
later
resolv
case
viral
load
decreas
log
copiesml
day
respect
rhinoviru
rna
viral
load
data
qpcr
result
respiratori
virus
avail
case
show
prolong
presenc
supplement
tabl
addit
respiratori
virus
frequent
detect
prolong
rhinoviru
infect
coronavirus
detect
case
initi
detect
often
associ
respiratori
symptom
review
medic
record
infant
prolong
presenc
rhinoviru
rna
found
evid
underli
condit
gener
consid
result
persist
rv
infect
eg
asthma
hypogammaglobulinemia
immunodefici
disord
increas
use
molecular
diagnost
respiratori
virus
associ
increas
sensit
detect
biolog
clinic
signific
detect
viral
nucleic
acid
must
address
issu
complic
challeng
differenti
new
infect
flow
diagram
subject
specimen
includ
studi
detect
rhinoviru
strain
followup
specimen
neg
particular
rhinoviru
strain
collect
within
day
followup
specimen
posit
rhinoviru
strain
collect
interv
restrict
day
rtpcr
reversetranscript
polymeras
chain
reaction
rv
rhinoviru
hypothet
subject
terminolog
use
studi
subject
rhinoviru
rna
isol
detect
distinct
rhinoviru
infect
rv
rhinoviru
prolong
viru
presencepersist
focus
studi
common
viral
infect
respiratori
tract
infant
first
year
life
data
larg
longitudin
studi
show
frequent
infect
differ
rhinoviru
strain
common
infant
first
year
life
importantli
result
indic
rhinoviru
rna
rare
persist
beyond
day
rhinoviru
infect
distinct
rhinoviru
infect
document
select
analysi
rhinoviru
infect
avail
followup
specimen
within
day
show
prolong
presenc
rhinoviru
strain
consist
earlier
studi
examin
persist
adenoviru
nucleic
acid
nasopharyng
secret
use
cutoff
defin
prolong
presenc
rhinoviru
rna
studi
also
use
time
limit
distinguish
new
repeat
nucleic
acid
detect
rhinoviru
infect
analyz
followup
specimen
neg
specif
rhinoviru
strain
find
provid
strong
evid
rhinoviru
strain
perman
rather
transient
absent
clinic
find
associ
lack
symptom
like
indic
resolut
infect
rhinoviru
infect
evalu
rna
detect
singl
specimen
infect
show
repeat
detect
strain
half
repeat
rhinoviru
rna
event
day
durat
major
repeat
posit
occur
within
window
among
infect
repeat
isol
total
isol
averag
per
infect
major
infect
isol
sever
none
repeat
rhinoviru
rna
isol
detect
day
apart
definit
prolong
presenc
evalu
rhinoviru
infect
infant
rhinovirusposit
specimen
sequenc
data
differ
rhinoviru
infect
followup
wherea
singl
rhinoviru
infect
studi
period
infant
infect
varieti
rhinoviru
strain
throughout
first
year
life
inde
data
show
repeat
detect
rhinoviru
rna
nasopharyng
specimen
infant
like
repres
new
infect
prolong
presenc
day
among
rhinoviru
infect
studi
occurr
rhinoviru
strain
replac
differ
strain
within
followup
period
compar
prolong
rhinoviru
infect
persist
rhinoviru
infect
prolong
presenc
rhinoviru
rna
describ
usual
patient
underli
condit
wood
et
al
examin
rhinoviru
rna
persist
subject
children
adult
acut
asthma
patient
follow
week
posthospit
admiss
posit
viral
specimen
sequenc
analysi
perform
difficult
assess
frequent
persist
rhinoviru
strain
occur
chronic
rhinoviru
infect
persist
rna
also
describ
transplant
patient
hypogammaglobulinemia
jartti
et
al
studi
serial
rhinoviru
infect
infant
risk
develop
asthma
consid
moderatetosever
rhinoviru
infect
associ
rhinoviru
strain
detect
least
week
apart
studi
includ
rhinoviru
occurr
regardless
symptom
observ
higher
rate
rhinoviru
persist
day
day
surpris
unlik
studi
includ
jartti
studi
infant
risk
asthma
infant
studi
underli
condit
